Global Prostate Specific Antigen Biomarker Market

Global Prostate Specific Antigen (PSA) Biomarker Market Research Report 2021

Global Prostate Specific Antigen Biomarker Market

Global Prostate Specific Antigen (PSA) Biomarker Market Research Report 2021


The Prostate Specific Antigen (PSA) Biomarker study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Prostate Specific Antigen (PSA) Biomarker Market Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Prostate Specific Antigen (PSA) Biomarker Market Market Overview:

Global Prostate Specific Antigen (PSA) Biomarker Market Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Prostate Specific Antigen (PSA) Biomarker Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Prostate Specific Antigen (PSA) Biomarker Market Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Prostate Specific Antigen (PSA) Biomarker Market market in 2020.

Global Prostate Specific Antigen (PSA) Biomarker Market Market Segmentation

By Type, Prostate Specific Antigen (PSA) Biomarker Market market has been segmented into:

Blood

Semen

Urine

By Application, Prostate Specific Antigen (PSA) Biomarker Market market has been segmented into:

Diagnostics

Drug Discovery

Personalized Medicine

Others

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Prostate Specific Antigen (PSA) Biomarker Market market are:

Abbott

Siemens Healthcare

DiaSorin

Roche

Tosoh Bioscience

Fujirebio

BodiTech

GE Healthcare

Endocare

Quest Diagnostics

Bio-Rad Laboratories

QIAGEN

Myriad RBM

1. Market Overview of Prostate Specific Antigen (PSA) Biomarker Market

1.1 Prostate Specific Antigen (PSA) Biomarker Market Market Overview

1.1.1 Prostate Specific Antigen (PSA) Biomarker Market Product Scope

1.1.2 Market Status and Outlook

1.2 Prostate Specific Antigen (PSA) Biomarker Market Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Prostate Specific Antigen (PSA) Biomarker Market Historic Market Size by Regions (2015-2020)

1.4 Prostate Specific Antigen (PSA) Biomarker Market Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Prostate Specific Antigen (PSA) Biomarker Market Sales Market by Type (2015-2026)

2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Historic Market Size by Type (2015-2020)

2.2 Global Prostate Specific Antigen (PSA) Biomarker Market Forecasted Market Size by Type (2021-2026)

2.3 Blood

2.4 Semen

2.5 Urine

3. Covid-19 Impact Prostate Specific Antigen (PSA) Biomarker Market Sales Market by Application (2015-2026)

3.1 Global Prostate Specific Antigen (PSA) Biomarker Market Historic Market Size by Application (2015-2020)

3.2 Global Prostate Specific Antigen (PSA) Biomarker Market Forecasted Market Size by Application (2021-2026)

3.3 Diagnostics

3.4 Drug Discovery

3.5 Personalized Medicine

3.6 Others

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Prostate Specific Antigen (PSA) Biomarker Market Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Prostate Specific Antigen (PSA) Biomarker Market Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Prostate Specific Antigen (PSA) Biomarker Market Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Prostate Specific Antigen (PSA) Biomarker Market Business

5.1 Abbott

5.1.1 Abbott Company Profile

5.1.2 Abbott Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Siemens Healthcare

5.2.1 Siemens Healthcare Company Profile

5.2.2 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 DiaSorin

5.3.1 DiaSorin Company Profile

5.3.2 DiaSorin Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Roche

5.4.1 Roche Company Profile

5.4.2 Roche Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 Tosoh Bioscience

5.5.1 Tosoh Bioscience Company Profile

5.5.2 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Fujirebio

5.6.1 Fujirebio Company Profile

5.6.2 Fujirebio Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 BodiTech

5.7.1 BodiTech Company Profile

5.7.2 BodiTech Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 GE Healthcare

5.8.1 GE Healthcare Company Profile

5.8.2 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 Endocare

5.9.1 Endocare Company Profile

5.9.2 Endocare Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 Quest Diagnostics

5.10.1 Quest Diagnostics Company Profile

5.10.2 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 Bio-Rad Laboratories

5.11.1 Bio-Rad Laboratories Company Profile

5.11.2 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 QIAGEN

5.12.1 QIAGEN Company Profile

5.12.2 QIAGEN Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 Myriad RBM

5.13.1 Myriad RBM Company Profile

5.13.2 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Market Product Specification

5.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Market Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Prostate Specific Antigen (PSA) Biomarker Market Market Size (2015-2026)

6.2 North America Prostate Specific Antigen (PSA) Biomarker Market Key Players in North America (2015-2020)

6.3 North America Prostate Specific Antigen (PSA) Biomarker Market Market Size by Type (2015-2020)

6.4 North America Prostate Specific Antigen (PSA) Biomarker Market Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Prostate Specific Antigen (PSA) Biomarker Market Market Size (2015-2026)

7.2 East Asia Prostate Specific Antigen (PSA) Biomarker Market Key Players in North America (2015-2020)

7.3 East Asia Prostate Specific Antigen (PSA) Biomarker Market Market Size by Type (2015-2020)

7.4 East Asia Prostate Specific Antigen (PSA) Biomarker Market Market Size by Application (2015-2020)

8. Europe

8.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Market Size (2015-2026)

8.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Key Players in North America (2015-2020)

8.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Market Size by Type (2015-2020)

8.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Prostate Specific Antigen (PSA) Biomarker Market Market Size (2015-2026)

9.2 South Asia Prostate Specific Antigen (PSA) Biomarker Market Key Players in North America (2015-2020)

9.3 South Asia Prostate Specific Antigen (PSA) Biomarker Market Market Size by Type (2015-2020)

9.4 South Asia Prostate Specific Antigen (PSA) Biomarker Market Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Market Size (2015-2026)

10.2 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Key Players in North America (2015-2020)

10.3 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Market Size by Type (2015-2020)

10.4 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Prostate Specific Antigen (PSA) Biomarker Market Market Size (2015-2026)

11.2 Middle East Prostate Specific Antigen (PSA) Biomarker Market Key Players in North America (2015-2020)

11.3 Middle East Prostate Specific Antigen (PSA) Biomarker Market Market Size by Type (2015-2020)

11.4 Middle East Prostate Specific Antigen (PSA) Biomarker Market Market Size by Application (2015-2020)

12. Africa

12.1 Africa Prostate Specific Antigen (PSA) Biomarker Market Market Size (2015-2026)

12.2 Africa Prostate Specific Antigen (PSA) Biomarker Market Key Players in North America (2015-2020)

12.3 Africa Prostate Specific Antigen (PSA) Biomarker Market Market Size by Type (2015-2020)

12.4 Africa Prostate Specific Antigen (PSA) Biomarker Market Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Prostate Specific Antigen (PSA) Biomarker Market Market Size (2015-2026)

13.2 Oceania Prostate Specific Antigen (PSA) Biomarker Market Key Players in North America (2015-2020)

13.3 Oceania Prostate Specific Antigen (PSA) Biomarker Market Market Size by Type (2015-2020)

13.4 Oceania Prostate Specific Antigen (PSA) Biomarker Market Market Size by Application (2015-2020)

14. South America

14.1 South America Prostate Specific Antigen (PSA) Biomarker Market Market Size (2015-2026)

14.2 South America Prostate Specific Antigen (PSA) Biomarker Market Key Players in North America (2015-2020)

14.3 South America Prostate Specific Antigen (PSA) Biomarker Market Market Size by Type (2015-2020)

14.4 South America Prostate Specific Antigen (PSA) Biomarker Market Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Prostate Specific Antigen (PSA) Biomarker Market Market Size (2015-2026)

15.2 Rest of the World Prostate Specific Antigen (PSA) Biomarker Market Key Players in North America (2015-2020)

15.3 Rest of the World Prostate Specific Antigen (PSA) Biomarker Market Market Size by Type (2015-2020)

15.4 Rest of the World Prostate Specific Antigen (PSA) Biomarker Market Market Size by Application (2015-2020)

16 Prostate Specific Antigen (PSA) Biomarker Market Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Prostate Specific Antigen (PSA) Biomarker Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Prostate Specific Antigen (PSA) Biomarker Market?
Some of the finest and top-notch companies pioneering the Prostate Specific Antigen (PSA) Biomarker Market are Abbott, Siemens Healthcare, DiaSorin, Roche, Tosoh Bioscience, Fujirebio, BodiTech, GE Healthcare, Endocare, Quest Diagnostics, Bio-Rad Laboratories, QIAGEN, Myriad RBM.
How is the competition changing gears in the Prostate Specific Antigen (PSA) Biomarker Industry?
Emerging markets will create new demands and put pressure on the industry to act quickly. Simultaneously, market players such as Abbott, Siemens Healthcare, DiaSorin, Roche, Tosoh Bioscience, Fujirebio, BodiTech, GE Healthcare, Endocare, Quest Diagnostics, Bio-Rad Laboratories, QIAGEN, Myriad RBM will face challenges from the industry's increasing pace of consolidation, particularly in North America and Europe.
Who are the significant end-users in the Prostate Specific Antigen (PSA) Biomarker Market?
The key end-users in the Prostate Specific Antigen (PSA) Biomarker Market are Market, Diagnostics, Drug Discovery, Personalized Medicine, Others
What is the forecasted growth rate of the Prostate Specific Antigen (PSA) Biomarker Market?
The Prostate Specific Antigen (PSA) Biomarker Market is expected to grow at a moderate CAGR during the forecast period of 2025 to 2030.
In the current situation, what value does the Prostate Specific Antigen (PSA) Biomarker Market have?
The value of the Prostate Specific Antigen (PSA) Biomarker Market is estimated to be USD XXX million.
What is the CAGR at which the Prostate Specific Antigen (PSA) Biomarker Market can expand?
During the forecast years, the Prostate Specific Antigen (PSA) Biomarker Market can thrive with a robust CAGR.